UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia

The New England journal of medicine, 2023-10, Vol.389 (15), p.1390-1401

2023

Volltextzugriff (PDF)

Successful treatment of infective endocarditis due to pandrug-resistant Klebsiella pneumoniae with ceftazidime-avibactam and aztreonam

Scientific reports, 2021-05, Vol.11 (1), p.9684-9, Article 9684

2021

Volltextzugriff (PDF)

Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis

American journal of respiratory and critical care medicine, 2008-11, Vol.178 (9), p.921-928

2008

Volltextzugriff (PDF)

Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis

Chest, 2009-05, Vol.135 (5), p.1223-1232

2009

Volltextzugriff (PDF)

Lung clearance index to detect the efficacy of Aztreonam lysine inhalation in patients with cystic fibrosis and near normal spirometry - A single-centre feasibility study

PloS one, 2019-09, Vol.14 (9), p.e0221673

2019

Volltextzugriff (PDF)

Tolerability of aztreonam and carbapenems in patients with IgE-mediated hypersensitivity to penicillins

Journal of allergy and clinical immunology, 2015-04, Vol.135 (4), p.972-976

2015

Volltextzugriff (PDF)

Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double-Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin-Structure Infection

Clinical infectious diseases, 2010-09, Vol.51 (6), p.641-650

2010

Volltextzugriff (PDF)

CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

Journal of antimicrobial chemotherapy, 2010-11, Vol.65 (suppl-4), p.iv53-iv65

2010

Volltextzugriff (PDF)

CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

Journal of antimicrobial chemotherapy, 2010-11, Vol.65 (suppl-4), p.iv41-iv51

2010

Volltextzugriff (PDF)

Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study

Journal of antimicrobial chemotherapy, 2017-12, Vol.72 (12), p.3471-3480

2017

Volltextzugriff (PDF)

An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis

Pediatric pulmonology, 2010-11, Vol.45 (11), p.1121-1134

2010

Volltextzugriff (PDF)

Pharmacokinetics of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase 1, Open-Label Study of Healthy Adults

Antimicrobial agents and chemotherapy, 2022-12, Vol.66 (12), p.e0093622

2022

Volltextzugriff (PDF)

Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis

Cochrane database of systematic reviews, 2022-11, Vol.11 (11), p.CD001021-CD001021

2022

Volltextzugriff (PDF)

Safety of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase I, Open-Label Study in Healthy Adult Volunteers

Antimicrobial agents and chemotherapy, 2022-12, Vol.66 (12), p.e0093522

2022

Volltextzugriff (PDF)

A Randomized, Evaluator-Blind, Phase 2 Study Comparing the Safety and Efficacy of Omadacycline to Those of Linezolid for Treatment of Complicated Skin and Skin Structure Infections

Antimicrobial Agents and Chemotherapy, 2012-11, Vol.56 (11), p.5650-5654

2012

Volltextzugriff (PDF)

Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials

The lancet respiratory medicine, 2014-09, Vol.2 (9), p.738-749

2014

Volltextzugriff (PDF)

Evaluation of Aztreonam Dosing Regimens in Patients With Normal and Impaired Renal Function: A Population Pharmacokinetic Modeling and Monte Carlo Simulation Analysis

Journal of clinical pharmacology, 2017-03, Vol.57 (3), p.336-344

2017

Volltextzugriff (PDF)

Cross-reactivity and tolerability of aztreonam and cephalosporins in subjects with a T cell–mediated hypersensitivity to penicillins

Journal of allergy and clinical immunology, 2016-07, Vol.138 (1), p.179-186

2016

Volltextzugriff (PDF)

Clinical and genomic characteristics of IMP-producing Enterobacter cloacae complex and Klebsiella pneumoniae

Antimicrobial agents and chemotherapy, 2024-05, Vol.68 (5), p.e0167223

2024

Volltextzugriff (PDF)

Difficult-to-treat (DTR) Pseudomonas aeruginosa harboring Verona-Integron metallo-β-lactamase ( bla VIM ): infection management and molecular analysis

Antimicrobial agents and chemotherapy, 2024-05, Vol.68 (5), p.e0147423

2024

Volltextzugriff (PDF)

Safety and Efficacy of Tigecycline in Treatment of Skin and Skin Structure Infections: Results of a Double-Blind Phase 3 Comparison Study with Vancomycin-Aztreonam

Antimicrobial Agents and Chemotherapy, 2005-11, Vol.49 (11), p.4658-4666

2005

Volltextzugriff (PDF)

The effects of inhaled aztreonam on the cystic fibrosis lung microbiome

Microbiome, 2017-05, Vol.5 (1), p.51-14, Article 51

2017

Volltextzugriff (PDF)

Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study

Journal of antimicrobial chemotherapy, 2020-03, Vol.75 (3), p.618-627

2020

Volltextzugriff (PDF)

A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities

Journal of antimicrobial chemotherapy, 2016-12, Vol.71 (12), p.3575-3584

2016

Volltextzugriff (PDF)

Repurposing an old drug: aztreonam as a new treatment strategy for gonorrhoea

Journal of antimicrobial chemotherapy, 2017-05, Vol.72 (5), p.1466-1468

2017

Volltextzugriff (PDF)

1 – 25 von 403

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(320)
Mit Volltextzugriff
(263)

Publikationsform

Artikel
(402)
magazinearticle
(1)

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(403)
Female
(312)
Male
(292)
Middle Aged
(260)
Science & Technology
(257)
Life Sciences & Biomedicine
(251)
Aztreonam - Therapeutic Use
(229)
Aged
(214)
Adolescent
(147)
Aztreonam
(127)
Aztreonam - Administration & Dosage
(125)
Pharmacology & Pharmacy
(125)
Bacterial Infections - Drug Therapy
(117)
Biological And Medical Sciences
(114)
Medical Sciences
(114)
Microbiology
(107)
Pharmacology. Drug Treatments
(100)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(96)
Antibacterial Agents
(93)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia

Successful treatment of infective endocarditis due to pandrug-resistant Klebsiella pneumoniae with ceftazidime-avibactam and aztreonam

Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis

Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis

Lung clearance index to detect the efficacy of Aztreonam lysine inhalation in patients with cystic fibrosis and near normal spirometry - A single-centre feasibility study

Tolerability of aztreonam and carbapenems in patients with IgE-mediated hypersensitivity to penicillins

Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double-Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin-Structure Infection

CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study

An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis

Pharmacokinetics of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase 1, Open-Label Study of Healthy Adults

Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis

Safety of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase I, Open-Label Study in Healthy Adult Volunteers

A Randomized, Evaluator-Blind, Phase 2 Study Comparing the Safety and Efficacy of Omadacycline to Those of Linezolid for Treatment of Complicated Skin and Skin Structure Infections

Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials

Evaluation of Aztreonam Dosing Regimens in Patients With Normal and Impaired Renal Function: A Population Pharmacokinetic Modeling and Monte Carlo Simulation Analysis

Cross-reactivity and tolerability of aztreonam and cephalosporins in subjects with a T cell–mediated hypersensitivity to penicillins

Clinical and genomic characteristics of IMP-producing Enterobacter cloacae complex and Klebsiella pneumoniae

Difficult-to-treat (DTR) Pseudomonas aeruginosa harboring Verona-Integron metallo-β-lactamase ( bla VIM ): infection management and molecular analysis

Safety and Efficacy of Tigecycline in Treatment of Skin and Skin Structure Infections: Results of a Double-Blind Phase 3 Comparison Study with Vancomycin-Aztreonam

The effects of inhaled aztreonam on the cystic fibrosis lung microbiome

Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study

A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities

Repurposing an old drug: aztreonam as a new treatment strategy for gonorrhoea

Aktive Filter

Suchergebnisse filtern